Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Triantafyllou K, Gkolfakis P, Gralnek IM, Oakland K, Manes G, Radaelli F, Awadie H, Camus Duboc M, Christodoulou D, Fedorov E, Guy RJ, Hollenbach M, Ibrahim M, Neeman Z, Regge D, Rodriguez de Santiago E, Tham TC, Thelin-Schmidt P, van Hooft JE.
Endoscopy. 2021 Aug;53(8):850-868. doi: 10.1055/a-1496-8969. Epub 2021 Jun 1.
Lower gastrointestinal bleeding.
Bounds BC, Friedman LS.
Gastroenterol Clin North Am. 2003 Dec;32(4):1107-25. doi: 10.1016/s0889-8553(03)00086-4.
Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology.
Romano C, Oliva S, Martellossi S, Miele E, Arrigo S, Graziani MG, Cardile S, Gaiani F, de'Angelis GL, Torroni F.
World J Gastroenterol. 2017 Feb 28;23(8):1328-1337. doi: 10.3748/wjg.v23.i8.1328.
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants.
Benamouzig R, Guenoun M, Deutsch D, Fauchier L.
Cardiovasc Drugs Ther. 2022 Oct;36(5):973-989. doi: 10.1007/s10557-021-07211-0. Epub 2021 Jun 18.
Non-variceal Upper Gastrointestinal Bleeding and Its Endoscopic Management.
Wasserman RD, Abel W, Monkemuller K, Yeaton P, Kesar V, Kesar V.
Turk J Gastroenterol. 2024 May 20;35(8):599-608. doi: 10.5152/tjg.2024.23507.
Acute lower gastrointestinal bleeding.
Jocić T, Latinović Bošnjak O, Hadnađev L, Damjanov D, Savić Ž, Orlić T.
Med Pregl. 2014 Nov-Dec;67(11-12):361-6. doi: 10.2298/mpns1412361j.
Does this patient have a severe upper gastrointestinal bleed?
Srygley FD, Gerardo CJ, Tran T, Fisher DA.
JAMA. 2012 Mar 14;307(10):1072-9. doi: 10.1001/jama.2012.253.
Hemosuccus Pancreaticus.
Shetty S, Shenoy S, Costello R, Adeel MY, Arora A.
J Ayub Med Coll Abbottabad. 2019 Oct-Dec;31(4):622-626.
Imaging Workup of Acute and Occult Lower Gastrointestinal Bleeding.
Morrison TC, Wells M, Fidler JL, Soto JA.
Radiol Clin North Am. 2018 Sep;56(5):791-804. doi: 10.1016/j.rcl.2018.04.009.
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial.
Srivastava A, Rangarajan S, Kavakli K, Klamroth R, Kenet G, Khoo L, You CW, Xu W, Malan N, Frenzel L, Bagot CN, Stasyshyn O, Chang CY, Poloskey S, Qiu Z, Andersson S, Mei B, Pipe SW.
Lancet Haematol. 2023 May;10(5):e322-e332. doi: 10.1016/S2352-3026(23)00037-6. Epub 2023 Mar 29.
